These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20870897)

  • 21. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
    Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
    Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of experimental retinal neovascularization to thiazolidinediones.
    Murata T; Hata Y; Ishibashi T; Kim S; Hsueh WA; Law RE; Hinton DR
    Arch Ophthalmol; 2001 May; 119(5):709-17. PubMed ID: 11346398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of troglitazone on AMPK in HepG2 cells.
    Allen KM; Coughlan KA; Mahmood FN; Valentine RJ; Ruderman NB; Saha AK
    Arch Biochem Biophys; 2017 Jun; 623-624():49-57. PubMed ID: 28526426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
    Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
    PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.
    Rachek LI; Yuzefovych LV; Ledoux SP; Julie NL; Wilson GL
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):348-54. PubMed ID: 19632256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troglitazone, a PPAR-γ agonist, decreases LTC
    Luczak E; Wieczfinska J; Sokolowska M; Pniewska E; Luczynska D; Pawliczak R
    Pharmacol Rep; 2017 Dec; 69(6):1315-1321. PubMed ID: 29128815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the K(ATP) channel and insulin secretion in rats.
    Chang TJ; Chen WP; Yang C; Lu PH; Liang YC; Su MJ; Lee SC; Chuang LM
    Diabetologia; 2009 Jun; 52(6):1112-21. PubMed ID: 19357830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK.
    Deng R; Nie A; Jian F; Liu Y; Tang H; Zhang J; Zhang Y; Shao L; Li F; Zhou L; Wang X; Ning G
    Biochim Biophys Acta; 2014 Jan; 1840(1):577-85. PubMed ID: 24144566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
    Gardner OS; Shiau CW; Chen CS; Graves LM
    J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolidinediones, a class of anti-diabetic drugs, inhibit Id2 expression through a PPARgamma-independent pathway in human aortic smooth muscle cells.
    Zhu X; Lin Y; Zhang J; Fu M; Mao Z; Chen YE
    Cell Mol Life Sci; 2003 Jan; 60(1):212-8. PubMed ID: 12613669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells.
    Lau JY; Oliver BG; Moir LM; Black JL; Burgess JK
    Respirology; 2010 Feb; 15(2):303-12. PubMed ID: 20070588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
    de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
    J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.
    Kawai T; Masaki T; Doi S; Arakawa T; Yokoyama Y; Doi T; Kohno N; Yorioka N
    Lab Invest; 2009 Jan; 89(1):47-58. PubMed ID: 19002105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.
    Xu Y; Gen M; Lu L; Fox J; Weiss SO; Brown RD; Perlov D; Ahmad H; Zhu P; Greyson C; Long CS; Schwartz GG
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1314-23. PubMed ID: 15528232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
    Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
    PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.